| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
| DEFA1 |
P59665
|
defensin alpha 1
|
|
|
0.636 |
0.731 |
| FSHMD1A |
|
facioscapulohumeral muscular dystrophy 1A
|
|
|
0.638 |
0.808 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| PRKY |
O43930
|
protein kinase Y-linked (pseudogene)
|
Kinase
|
|
0.839 |
0.192 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| GHS |
|
Goldenhar syndrome
|
|
|
0.659 |
0.615 |
| FCGR2C |
P31995
|
Fc fragment of IgG receptor IIc (gene/pseudogene)
|
Cell adhesion
|
|
0.610 |
0.654 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| FCMTE1 |
|
familial cortical myoclonic tremor with epilepsy 1
|
|
|
0.769 |
0.231 |
| CES1P1 |
Q9UKY3
|
carboxylesterase 1 pseudogene 1
|
Enzyme
|
|
0.861 |
0.077 |
| HDL3 |
|
Huntington-like neurodegenerative disorder 2
|
|
|
0.663 |
0.423 |
| KMT5AP1 |
|
KMT5A pseudogene 1
|
|
|
0.716 |
0.423 |
| CPAT1 |
|
cerebral palsy, ataxic 1
|
|
|
0.674 |
0.654 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| GMCL2 |
Q8NEA9
|
germ cell-less 2, spermatogenesis associated
|
|
|
0.751 |
0.308 |
| LPAL2 |
Q16609
|
lipoprotein(a) like 2, pseudogene
|
Enzyme
|
|
0.626 |
0.731 |